We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




AI Diagnostic Tool Could Deliver Results in Two Minutes Using Fingertip Sample

By LabMedica International staff writers
Posted on 21 Oct 2022
Print article
Image: The μ-rheometer evaluates liquid properties such as viscosity using fingerpick samples (Photo courtesy of Swansea University)
Image: The μ-rheometer evaluates liquid properties such as viscosity using fingerpick samples (Photo courtesy of Swansea University)

Biofluids such as synovial fluid, blood plasma, and saliva contain proteins that are an important biomarker for the diagnosis of several health conditions. Now, a specially designed platform has been programmed to detect the concentration of these proteins to assist in diagnosis and monitoring disease progression. The research proposes that hospital waiting times could be drastically cut and the option for self-screening and self-monitoring is now possible with the potential for at-home diagnostic kits in the future.

Scientists at Swansea University (Swansea, UK) developing a platform that would use artificial intelligence (AI) to speed up the process of detecting biomarkers in biofluids have shown that the concept could work. It would mean faster test results for health conditions such as cardiovascular disorders, joint quality, and Alzheimer’s disease. The new diagnostic tool could revolutionize the healthcare sector due to the application of a form of AI – machine learning (ML). The implementation of ML has meant it is possible, for the first time, for results to be delivered within minutes.

“The key innovation is the fact of providing a result within two minutes, which is a leap forward compared to standard testing that can take several hours,” said Dr. Francesco Del Giudice, project lead. "What this means for the future is that our proof-of-concept study can be further developed in a tool to help clinicians making decisions on clinical data obtained quickly. We also foresee to develop this further for an at-home-point-of-care self-screening diagnostic platform.”

“The ability of artificial intelligence to drive down the time required to complete various tasks has been demonstrated across a number of disciplines,” added Dr. Claire Barnes, co-author on the work. “The advantage of speed offered by the implementation of machine learning allowed us to adjust almost in real-time the experimental parameters to fulfill the requirements of the theoretical model associated with this work.”

Related Links:
Swansea University 

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Quantitative Immunoassay Analyzer
AS050
New
ELISA System
ABSOL HS DUO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.